The Excellence in Oncology Conference, 18th-20th November 2010, Athens, Greece
european cancer organisation swissbridge
ISSN: 1754-6605

News

Insider News

Insider News

Frankincense oil derived from Boswellia carteri induces bladder tumor cell specific cytotoxicity

Published: 18/03/2009 - PDF Version (117 KB)

Frankincense oil - a potential treatment option for bladder cancer

An enriched extract of the Somalian Frankincense herb Boswellia carteri has been shown to kill off bladder cancer cells. Frankincense oil is prepared from aromatic hardened gum resins obtained by tapping Boswellia trees. One of the main components of frankincense oil is boswellic acid, a component known to have anti-neoplastic properties. Research presented in the peer reviewed journal, BMC Complementary and Alternative Medicine found that  Frankincense oil might represent an alternative intravesical agent for bladder cancer treatment.

HK Lin and his team, from the University of Oklahoma Health Sciences Center and Oklahoma City VA Medical Center, set out to evaluate frankincense oil for its anti-tumour activity in bladder cancer cells. The authors investigated the effects of the oil in two different types of cells in culture: human bladder cancer cells and normal bladder cells. The team found that frankincense oil is able to discriminate between normal and cancerous bladder cells in culture, and specifically kill cancer cells.

Within a range of concentration, frankincense oil suppressed cell viability in bladder transitional carcinoma J82 cells but not in UROtsa cells. Comprehensive gene expression analysis confirmed that frankincense oil activates genes that are responsible for cell cycle arrest, cell growth suppression, and apoptosis in J82 cells. However, frankincense oil-induced cell death in J82 cells did not result in DNA fragmentation, a hallmark of apoptosis.

Article: Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity
Mark Barton Frank, Qing Yang, Jeanette Osban, Joseph T Azzarello, Marcia R Saban, Ricardo Saban, Richard A Ashley, Jan C Welter, Kar-Ming Fung and Hsueh-Kung Lin http://www.biomedcentral.com/bmccomplementalternmed/

 

Comments

20/03/2009 11:12:30
Comment by Stuart

Presumably the word "intravesical" means intoduced directly into the bladder, and so is a surgical treatment, and not something that can be administered by the patient him/herself?



Unsuitable? Report this comment    

20/03/2009 11:12:55
Comment by ecancer

Yes, likely delivered through a catheter.



Unsuitable? Report this comment    

08/05/2009 12:59:03
Comment by a reader

Is this treatment available in China?



Unsuitable? Report this comment    


Also in the news

 

Post a comment

Your Details
Verification
  1. Please re-type the words exactly as shown below (this is for anti-spam purposes):

Follow us on Twitter
Submit Now
Editorial Profiles
Eurocancercoms. An exciting new project looking at the issues surrounding communication and dissemination of cancer information across Europe
call to advertise here +44 (0) 20 8544 1050